ABSTRACTS Friday, April 15, <strong>2005</strong> <strong>SAGES</strong> <strong>2005</strong> shorter hospital stay (4.1 vs. 6.2 days, p0.38). Patients with ruptured appendicitis had a shorter Time to Surgery (P=0.056). Patients with LA had a shorter LOS than OA (1.6 days reduction). This LOS was significantly shorter among those with ruptured appendicitis vs non-ruptured appendicitis (2.0 days vs 0.3 day reduction). Rank-order multiple regression analysis, controlling for all other factors, showed laparoscopy to have a significant effect on postoperative LOS in all appendicitis cases, especially ruptured appendicitis. Conclusions: The two-day reduction in LOS among those with ruptured appendicitis who underwent LA is significant enough to overcome the smaller benefit of LA in acute appendicitis. This is the largest prospective analysis of the effects of LA in ruptured appendicitis among adults in the U.S. Given these findings, LA is a superior approach for all patients with appendicitis. S078 10 YEAR OUTCOME OF LAPAROSCOPIC COLORECTAL RESEC- TION FOR CANCER, C Sample MD, M Watson MD,A Okrainec MD,R Gupta MD,D Birch MD,M Anvari PhD, Centre for Minimal Access Surgery, McMaster University, Hamilton Ontario Canada Multiple reports have outlined the potential benefits of the laparoscopic approach to colon surgery. Recently, randomized control trials have demonstrated the safety of applying these techniques to colorectal cancer over a 5 year follow-up. We examined our results for laparoscopic colorectal cancer resections with a 10 year follow-up and compared them to a large prospective database of open resections. A total of 231 resections were performed for adenocarcinoma of the colon or rectum between November 1992 and November 2003. Of those resections, 93 were rectal (40.3%) and 138 were colonic (59.7%). 8 (3.2%) of the resections were performed as emergencies. 27 (11.7%) were converted to open. Mean OR time was 150.1 (+/- 59.2) minutes. Overall complication rate was 42.9% with 14 (5.6%) wound infections, 8 (3.2%) significant peri-operative bleeds, 1 (0.4%) ureteric injury and 1 (0.4%) anastomotic leak. There were 5 (2%) peri-operative deaths. Patients were followed up to 131.5 months. A total of 51 (22.1%) of patients had recurrence prior to death with 14 (6.1%) local and 37 (16%) distant recurrences. Only 2 patients had wound recurrences (0.8%) and both patients had widespread peritoneal recurrence at the time of diagnosis. Overall survival at 60 and 120 months was 65.3% and 60.3% respectively. Disease free survival at 60 and 120 months was 58% and 56% respectively. Conclusion: Laparoscopic techniques can be applied to a wide range of colorectal malignancies without sacrificing oncologic results at 10 year follow-up. S079 A RETROSPECTIVE, MULTICENTER STUDY ON LAPAROSCOP- IC SURGERY FOR GASTRIC AND COLORECTAL CANCER IN JAPAN, Seigo Kitano MD, Tsuyoshi Eto MD,Akio Shiromizu MD,Koichi Ishikawa MD,Masafumi Inomata MD,Norio Shiraishi MD, Department of Surgery I, Oita University Faculty of Medicine Objective: Laparoscopic surgery for malignant disease technically is feasible, but not widely accepted because of the lack of large-series studies and data on long-term outcomes. We conducted a retrospective, multicenter study of a large series of patients in Japan to evaluate long-term results of laparoscopic surgery for malignancies of stomach and colorectum. Methods: The study group comprised 1491 patients undergoing laparoscopy-assisted distal gastrectomy (LADG) for early gastric cancer, and 2036 patients undergoing laparoscopic colorectal resection for colorectal cancer during the period 1993 to 2002 in 18 participating surgical units (Japanese Laparoscopic Surgery Study Group). Results: In 1491 patients undergoing LADG, the morbidity and mortality rate was 12% and 0%. Recurrent rate was 0.4% and the 5-year disease free survival rate was 99.2%. In 1495 patients with colon cancer, the morbidity and mortality rate was 13% and 1%. Recurrent rate was 4% and the 5-year survival rate was 96.7% for stage I, 94.8% for stage II, and 79.6% for stage III disease. In the 541 patients with rectal cancer, the morbidity and mortality rate was 14% and 2%. Recurrent rate was 6% and the 5-year survival rate was 95.2% for stage I, 85.2% for stage II, and 80.8% for stage III disease. Conclusions: A retrospective, multicenter study demonstrates that laparoscopic surgery for early gastric and colorectal cancer is feasible in terms of long-term outcomes in Japan. S080 EXTRA VS INTRA-CORPOREAL ANASTOMOSIS IN LAPARO- SCOPIC RIGHT HEMICOLECTOMY - A RETROSPECTIVE ANALYSIS, Gideon Sroka MD, Amir Szold MD,Samuel Eldar MD,Ibrahim Matter MD, Department of general surgery, laparoscopic surgery unit , Bnai-zion medical center, Haifa, Israel. Background: Laparoscopic right hemicolectomy (LRH) has emerged, in the last decade, as a feasible and safe procedure, for either benign or malignant disease. Recently it has been proven to be an acceptable alternative to open surgery for colon cancer. Technically, two main issues differ surgeons in addressing this operation: 1. Right colon dissection could either be medio-lateral or vice versa. 2. The anastomosis could be performed either intra or extra-corporealy (laparoscopic assisted). So far there is no proven benefit to either approach. The purpose of this study is to evaluate patient outcome and complication rate related to anastomotic technique. Methods: Between 01/02 and 07/04 34 patients went through LRH in our department, 26 of them due to carcinoma of the right colon, 7 due to adenomatous polyp that was not amenable to colonoscopic resection and 1 due to colonic lymphoma. In all of the patients the approach was medio-lateral with identification of the ureter before opening Taldt?s fascia, 100 http://www.sages.org/
ABSTRACTS Friday, April 15, <strong>2005</strong> and early and high vascular ligation. 16 had extra-corporeall anastomosis and 18 went through a totally laparoscopic procedure according to surgeon preference. Results: Both groups were similar in patient age, sex, co-morbidities, operating time and blood loss. There was no difference in the number of lymph nodes dissected (mean 10, range 5-22), the distance of tumor from specimen?s margins (mean 6 cm, range 3-9.5 cm), or in pathological staging. In the laparoscopic assisted group 3 patients had anastomotic leak that mandated re-laparotomy and re-anastomosis. No patient had such a complication in the totally laparoscopic group.(p
- Page 1 and 2: ABSTRACTS Thursday, April 14, 2005
- Page 3 and 4: ABSTRACTS Thursday, April 14, 2005
- Page 5 and 6: ABSTRACTS Thursday, April 14, 2005
- Page 7 and 8: ABSTRACTS Thursday, April 14, 2005
- Page 9 and 10: ABSTRACTS Thursday, April 14, 2005
- Page 11 and 12: ABSTRACTS Thursday, April 14, 2005
- Page 13 and 14: ABSTRACTS Thursday, April 14, 2005
- Page 15 and 16: ABSTRACTS Thursday, April 14, 2005
- Page 17: ABSTRACTS Friday, April 15, 2005 en
- Page 21 and 22: ABSTRACTS Friday, April 15, 2005 to
- Page 23 and 24: ABSTRACTS Friday, April 15, 2005 to
- Page 25 and 26: ABSTRACTS Friday, April 15, 2005 in
- Page 27 and 28: ABSTRACTS Friday, April 15, 2005 co
- Page 29 and 30: ABSTRACTS Friday, April 15, 2005 Co
- Page 31 and 32: POSTER ABSTRACTS Posters of Distinc
- Page 33 and 34: POSTER ABSTRACTS P076 MURPHY, JASON
- Page 35 and 36: POSTER ABSTRACTS P152 CHOKKI, ADEL
- Page 37 and 38: POSTER ABSTRACTS P235 YASUI, M “L
- Page 39 and 40: POSTER ABSTRACTS P312 AGRESTA, FERD
- Page 41 and 42: POSTER ABSTRACTS FUNDOPLICATION TO
- Page 43 and 44: POSTER ABSTRACTS In two groups of 5
- Page 45 and 46: POSTER ABSTRACTS Carvalho PhD, Debo
- Page 47 and 48: POSTER ABSTRACTS tive procedures on
- Page 49 and 50: POSTER ABSTRACTS invasive procedure
- Page 51 and 52: POSTER ABSTRACTS allows identificat
- Page 53 and 54: POSTER ABSTRACTS Laparoscopic gastr
- Page 55 and 56: POSTER ABSTRACTS Results: A total o
- Page 57 and 58: POSTER ABSTRACTS P054-Bariatric Sur
- Page 59 and 60: POSTER ABSTRACTS laparoscopic Gastr
- Page 61 and 62: POSTER ABSTRACTS P070-Bariatric Sur
- Page 63 and 64: POSTER ABSTRACTS becomes increasing
- Page 65 and 66: POSTER ABSTRACTS MD,Ajay K Chopra M
- Page 67 and 68: POSTER ABSTRACTS to have a fewer co
- Page 69 and 70:
POSTER ABSTRACTS RESULTS: The mean
- Page 71 and 72:
POSTER ABSTRACTS surgeons working i
- Page 73 and 74:
POSTER ABSTRACTS One patient had un
- Page 75 and 76:
POSTER ABSTRACTS operative time, na
- Page 77 and 78:
POSTER ABSTRACTS divided to two maj
- Page 79 and 80:
POSTER ABSTRACTS tomies during this
- Page 81 and 82:
POSTER ABSTRACTS tumor. Discussion:
- Page 83 and 84:
POSTER ABSTRACTS to avoid dissemina
- Page 85 and 86:
POSTER ABSTRACTS sure of a gastric
- Page 87 and 88:
POSTER ABSTRACTS subjects had used
- Page 89 and 90:
POSTER ABSTRACTS (CS2) tasks, and 5
- Page 91 and 92:
POSTER ABSTRACTS P180-Education/Out
- Page 93 and 94:
POSTER ABSTRACTS laparoscopic equip
- Page 95 and 96:
POSTER ABSTRACTS defined borders, a
- Page 97 and 98:
POSTER ABSTRACTS B1.1?}0.3days, p =
- Page 99 and 100:
POSTER ABSTRACTS P210-Hepatobiliary
- Page 101 and 102:
POSTER ABSTRACTS P218-Basic Science
- Page 103 and 104:
POSTER ABSTRACTS P225-Complications
- Page 105 and 106:
POSTER ABSTRACTS perforated. Result
- Page 107 and 108:
POSTER ABSTRACTS J Lomax MD,Christi
- Page 109 and 110:
POSTER ABSTRACTS METHODS: A databas
- Page 111 and 112:
POSTER ABSTRACTS 3=severe). A total
- Page 113 and 114:
POSTER ABSTRACTS silluminated the a
- Page 115 and 116:
POSTER ABSTRACTS Introduction Radic
- Page 117 and 118:
POSTER ABSTRACTS and GERD symptom s
- Page 119 and 120:
POSTER ABSTRACTS performed followed
- Page 121 and 122:
POSTER ABSTRACTS this practice by t
- Page 123 and 124:
POSTER ABSTRACTS Esophageal aperist
- Page 125 and 126:
POSTER ABSTRACTS were rejected for
- Page 127 and 128:
POSTER ABSTRACTS LIHR group (27.5%
- Page 129 and 130:
POSTER ABSTRACTS adhesion between p
- Page 131 and 132:
POSTER ABSTRACTS P328-Hernia Surger
- Page 133 and 134:
POSTER ABSTRACTS urement tools. Rat
- Page 135 and 136:
POSTER ABSTRACTS CONCLUSION: The su
- Page 137 and 138:
POSTER ABSTRACTS Results: 7 perfora
- Page 139 and 140:
POSTER ABSTRACTS MS,Susan Hallbeck
- Page 141 and 142:
POSTER ABSTRACTS All complications
- Page 143 and 144:
POSTER ABSTRACTS In the past we foc
- Page 145 and 146:
POSTER ABSTRACTS Materials and Meth
- Page 147 and 148:
POSTER ABSTRACTS total traveling di
- Page 149 and 150:
POSTER ABSTRACTS Patients in both g
- Page 151 and 152:
POSTER ABSTRACTS P406-Solid Organ R
- Page 153 and 154:
POSTER ABSTRACTS stay period was 1.
- Page 155 and 156:
EMERGING TECHNOLOGY LUNCH ORAL ABST
- Page 157 and 158:
EMERGING TECHNOLOGY LUNCH ORAL ABST
- Page 159 and 160:
EMERGING TECHNOLOGY LUNCH POSTER AB
- Page 161 and 162:
EMERGING TECHNOLOGY LUNCH POSTER AB
- Page 163 and 164:
EMERGING TECHNOLOGY LUNCH POSTER AB
- Page 165 and 166:
EMERGING TECHNOLOGY LUNCH POSTER AB
- Page 167 and 168:
EMERGING TECHNOLOGY LUNCH POSTER AB